首页> 外文OA文献 >IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion

【2h】

IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion

机译：IL15通过连续静脉输注对成年患者在I期试验诱导的巨大肿瘤中的患者诱导的戏剧性NK细胞群扩张

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Kevin C. Conlon; E. Lake Potter; Stefania Pittaluga; Chyi-Chia Richard Lee; Milos D. Miljkovic; Thomas A. Fleisher; Sigrid Dubois; Bonita R. Bryant; Michael Petrus; Liyanage P. Perera; Jennifer Hsu; William D. Figg; Cody J. Peer; Joanna H. Shih; Jason L. Yovandich; Stephen P. Creekmore; Mario Roederer; Thomas A. Waldmann;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion [J] . Conlon Kevin C., Potter E. Lake, Pittaluga Stefania, Clinical cancer research: an official journal of the American Association for Cancer Research . 2019,第16期

机译：IL15通过连续静脉输注对成年患者在I期试验诱导的巨大肿瘤中的患者诱导的戏剧性NK细胞群扩张
2. Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trial. [J] . Weingart J, Grossman SA, Carson KA, Journal of Clinical Oncology . 2007,第4期

机译：成年复发性恶性神经胶质瘤成人患者中加用卡莫司汀植入物的polifeprosan 20 I期试验，连续输注静脉内O6-苄基鸟嘌呤：脑肿瘤治疗CNS联合体试验的新方法。
3. Phase I trial of continuous infusion 9-aminocamptothecin in patients with advanced solid tumors: 21-day infusion is an active well-tolerated regimen. [J] . Sewak S, Sorich J, Oleary J Anti-cancer drugs . 2006,第5期

机译：在晚期实体瘤患者中连续输注9-氨基喜树碱的I期试验：21天输注是一种有效的耐受性良好的方案。
4. Phase I Clinical Trial with Her-2 B-Cell Chimeric and MultiEpitope Based Peptide Vaccines in Patients with Metastatic and/or Recurrent Solid Tumors [C] . Pravin T.P. Kaumaya, Kevin Chu Foy, Joan Garrett American Peptide Symposium . 2009

机译：患者临床试验与患有转移和/或复发性固体瘤的患者的HER-2 B细胞嵌合和多型肽疫苗
5. A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin [D] . Venkatramani, Rajkumar. 2010

机译：长春新碱，伊非替康，替莫唑胺和贝伐单抗（VIT-B）逐步剂量在患有非造血源性复发或难治性实体瘤的儿童和青少年患者中的I期研究
6. IL-15 by continuous i.v. infusion to adult patients with solid tumors in a Phase I trial induced dramatic NK cell subset expansion [O] . Kevin C. Conlon, E. Lake Potter, Stefania Pittaluga, -1

机译：通过连续静脉注射IL-15在I期试验中向成人实体瘤患者输注可诱导NK细胞亚群急剧扩增
7. A phase I trial of intravenous infusion of ONYX-015 and enbrel in solid tumor patients [O] . J Nemunaitis, N Senzer, S Sarmiento, 2007

机译：I型试验静脉输注ONYX-015和实体肿瘤患者的嵌入

IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion

著录项

引文网络

相似文献

相关主题

期刊订阅